Sheel Biotech Schedules Board Meeting for Half-Year Financial Results and Fund Monitoring
Sheel Biotech Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Sheel Biotech Schedules Board Meeting for Half-Year Financial Results and Fund Monitoring Sheel Biotech Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited financial results alongside the Limited Review Report for the half-year ended 30th Sep'26. The board will also review the Monitoring Agency report regarding fund utilisation for the same period. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities remains closed until 48 hours post the declaration of these results.
Original exchange filing (PDF)
More announcements from Sheel Biotech Ltd
- Sheel Biotech Limited has informed the Exchange regarding 'Investor Presentation'. 路 17 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Monitoring Agency Report for the Half year ended on 30th September, 2026. 路 13 Nov 2026
- SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production. 路 30 Oct 2026
- Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026. 路 14 Oct 2026
- Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026 路 13 Oct 2026
